29th January 2022 | Pharma Updates
Leverage global biosimilar opportunity
In 2015 the Indian biosimilar market was around USD 300 mn, and it is expected to reach USD 40 bn in a few years.
Mansukh Mandaviya launches Research Portal
National Institute of Pharmaceutical Research’s research portal may help MSMEs.
Granules bags approval for potassium chloride for oral solution
“This will surely add value to our growing portfolio” , Ms. Priyanka Chigurupati, ED Granules India said.
Glenmark secures approval for metronidazole vaginal Gel
As of November 2021, the MetroGel Vaginal Gel, 0.75% market has made annual sales of around USD 60.4 mm.
DRL is making efforts to launch Sputnik M vaccine
The drug major is in discussion with India’s drug regulator about Russia’s Covid vaccine for 12 to 18 years of adolescents.
Dr. Reddy's clocks ₹709 cr profit this quarter
The pharma company posted a decline in impairment charges and improved sales in generics.
Bharat Biotech gets a nod for Intranasal vaccine clinical trials
The clinical trials for 0.5 ml single shot of nasal vaccine will be performed at nine sites across India.
